Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-hydroxyanthranilate oxidase is an oxidoreductase enzyme (EC 1.10.3.5) that catalyzes the oxidation of 3-hydroxyanthranilate in the presence of oxygen, forming 6-imino-5-oxocyclohexa-1,3-dienecarboxylate and hydrogen peroxide[4]. It is a rare enzyme, minimally studied in higher organisms, and should not be confused with 3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6), which is a well-characterized member of the kynurenine pathway with significant biological and therapeutic relevance. The oxidase has little evidence for involvement in human disease, biomarker applications, or as a drug target[4][5].
Not established for drugs (no drugs known) Catalyzes: 3-hydroxyanthranilate + O2 → 6-imino-5-oxocyclohexa-1,3-dienecarboxylate + H2O2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-hydroxyanthranilate oxidase.